Traditional Chinese medicine external application treatment method and system
Through microfluidic control technology, the microchannel and environmental monitoring system are designed, and the problems of uneven drug release and insufficient environmental adaptability in traditional external treatment are solved, and the accurate matching of drug release and the stability of treatment effect are achieved.
Patent Information
- Application Number
- CN202411175895.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-12-06
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Traditional external treatment techniques have limitations in drug release control and environmental adaptability, resulting in uneven drug distribution and unstable therapeutic effects, and the inability to fully realize the therapeutic potential of dressings.
Microfluidic technology is used to design the microchannel structure, combine temperature, humidity and pH sensors for environmental monitoring, use long and short-term memory network to analyze performance changes, select appropriate wrapping materials and optimize flow field layout, and ensure uniformity and stability of drug release sex.
The precise matching of drug release speed and path is achieved, the consistency and predictability of treatment effects are improved, and the dressings are significantly improved to respond to environmental changes, ensuring that the optimal therapeutic effect is maintained under various conditions.
Smart Images

Figure CN119074387A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of external application therapy, and in particular to a traditional Chinese medicine external application therapy method and system. Background Art
[0002] The field of topical treatment technology mainly involves treatment methods that act directly on specific body parts through the skin surface, aiming to utilize the local effects of drugs, natural herbs or other therapeutic substances to achieve the purpose of treating, alleviating or preventing diseases. Topical treatment has a wide range of applications, including but not limited to treating diseases of the musculoskeletal system, promoting wound healing, relieving pain, and treating skin diseases. By acting directly on specific parts of the body, the concentration of active ingredients can be locally increased, thereby achieving a rapid and effective treatment effect while reducing the risk of systemic side effects.
[0003] Among them, the external application treatment of traditional Chinese medicine is a treatment plan that combines traditional Chinese medicine pharmacology with modern external application technology. The core purpose is to use the characteristics of traditional Chinese medicine to directly act on the disease site or specific acupuncture points through external application to achieve the effect of treating or alleviating the disease. Its goal is not limited to the surface treatment of the disease, but also includes promoting the overall health and self-healing ability of the body by harmonizing the body's qi and blood and balancing yin and yang.
[0004] The limitations of traditional topical treatment technology in terms of drug release control and environmental adaptability are quite obvious. Dressings with fixed structures are difficult to adapt to the diversity of drug properties and usage environments, resulting in uneven distribution of drugs in vitro, affecting the efficiency of treatment. In addition, traditional dressings lack dynamic monitoring and adaptation mechanisms to changes in the usage environment. Environmental factors such as temperature and humidity changes may cause instability of the active ingredients, reduce the reliability of treatment, and cause the dressing to be unable to fully exert its therapeutic potential, limiting the maximization of the treatment effect. Summary of the invention
[0005] The purpose of the present invention is to solve the shortcomings of the prior art and to propose a method and system for external application of traditional Chinese medicine for treatment.
[0006] In order to achieve the above object, the present invention adopts the following technical scheme: a method for external application of traditional Chinese medicine comprises the following steps:
[0007] S1: Select appropriate matrix materials, design dressings based on the characteristics of Chinese medicine ingredients and skin permeability requirements, test the effect of the matrix on drug release, and obtain a dressing matrix design plan;
[0008] S2: Based on the dressing matrix design, the microfluidic technology is used to adjust the structure of the microchannel in the dressing, match the optimal release rate and path of the Chinese medicine ingredients, simulate the flow of the drug in the microchannel, optimize and match the drug release requirements, and generate a microchannel structure adjustment plan;
[0009] S3: using the microchannel structure adjustment scheme, configuring temperature, humidity and pH sensors, recording changes in the dressing use environment, and collecting data to obtain an environmental monitoring sensor network;
[0010] S4: applying the environmental monitoring sensor network to a long short-term memory network to analyze the performance changes of the dressing under different usage environments, identifying the key factors affecting the drug release rate and the air permeability of the dressing, and obtaining the analysis results of the dressing performance changes;
[0011] S5: According to the analysis results of the dressing performance changes, a wrapping material is selected to encapsulate the medicinal ingredients, and the stability under different conditions is tested to optimize and extend the service life of the drug, and a stability adjustment plan for the medicinal ingredients is obtained;
[0012] S6: Based on the stability adjustment plan of the active ingredient, optimize the internal flow field design of the microfluidic chip, adjust the flow field layout, test the drug distribution and release rate, meet the treatment needs, and obtain the drug release control optimization plan.
[0013] As a further scheme of the present invention, the dressing matrix design scheme includes the use of natural fibers, synthetic polymer materials and breathable adhesives, the microchannel structure adjustment scheme specifically adjusts the width and length of the microchannel and the coating type of the inner wall of the microchannel, the environmental monitoring sensor network includes a skin contact temperature monitoring sensor, a humidity monitoring sensor and a pH value monitoring sensor, the dressing performance change analysis results are specifically the air permeability data of the dressing under different humidity conditions and the data of the drug release rate at different temperatures, the active ingredient stability adjustment scheme includes the use of antioxidant coating materials, photosensitizers and humidity controllers, and the drug release control optimization scheme is specifically the adjustment of drug distribution uniformity, the release rate increment level and the optimization adjustment of the dressing to the skin.
[0014] As a further solution of the present invention, the steps of selecting a suitable matrix material, designing a dressing in combination with the characteristics of the Chinese medicine ingredients and the skin's breathability requirements, and testing the effect of the matrix on drug release to obtain a dressing matrix design solution are as follows:
[0015] S101: Select appropriate matrix materials, combine the chemical stability of Chinese medicine ingredients and the skin's absorption requirements for drugs, screen natural polymer materials and synthetic polymers with good air permeability and absorption performance, conduct preliminary dressing matrix ratio experiments, and obtain preliminary matrix material selection results;
[0016] S102: Based on the preliminary selection results of the matrix materials, the selected materials are tested for chemical and physical properties, including air permeability, hygroscopicity and drug release performance, the test data of the materials are compared, the matrix materials with the best characteristics of traditional Chinese medicine ingredients are identified, and the matrix material screening and refinement results are generated;
[0017] S103: Based on the screening and refinement results of the matrix material, combined with the characteristics of the traditional Chinese medicine ingredients and the skin permeability requirements, the effect of the matrix on drug release is tested, and the release efficiency and duration of the drug are optimized by adjusting the material ratio and hierarchical structure to obtain a dressing matrix design solution.
[0018] As a further solution of the present invention, based on the dressing matrix design scheme, the microfluidic technology is used to adjust the structure of the microchannel in the dressing, match the optimal release rate and path of the traditional Chinese medicine ingredients, simulate the flow of the drug in the microchannel, optimize and match the drug release requirements, and generate the microchannel structure adjustment scheme in the following steps:
[0019] S201: Based on the dressing matrix design scheme, a preliminary design diagram of a microchannel is drawn using microfluidic technology, and the preliminary width and length of the microchannel are determined in combination with the physical properties of the traditional Chinese medicine ingredients, including viscosity and fluidity, to generate a preliminary design diagram of the microchannel;
[0020] The microfluidic technology, according to the formula:
[0021]
[0022] Calculate the flow rate of the microchannel and generate a preliminary design diagram of the microchannel, where Q is the flow rate, ΔP is the pressure difference at both ends of the microchannel, d is the diameter of the microchannel, n is the non-Newtonian behavior index, and T vis is the coefficient of temperature on viscosity, μ is the dynamic viscosity, L is the length of the microchannel, S shape is the shape factor.
[0023] S202: Based on the preliminary design of the microchannel, a simulation test of drug flow in the microchannel is performed, the size of the microchannel is adjusted to ensure that the Chinese medicine components can be evenly diffused on the simulated skin surface, and a microchannel size adjustment plan is generated;
[0024] S203: Based on the microchannel size adjustment scheme, the microchannel structure is optimized to match the optimal release rate and path of the Chinese medicine ingredients, and an actual drug release test is performed to confirm the flow and release efficiency of the drug in the microchannel, and obtain a microchannel structure adjustment scheme.
[0025] As a further solution of the present invention, the steps of using the microchannel structure adjustment solution to configure temperature, humidity and pH sensors to record changes in the dressing use environment and collect data to obtain an environmental monitoring sensor network are as follows:
[0026] S301: According to the microchannel structure adjustment plan, a temperature sensor, a humidity sensor and a pH sensor are selected, and the placement and quantity of the sensors are determined to cover the key use area of the dressing, and obtain a sensor layout plan;
[0027] S302: Based on the sensor layout plan, install sensors in the dressing, connect data transmission lines, perform preliminary environmental monitoring tests, adjust the sensitivity and response time of the sensors, and generate sensor installation and test configurations;
[0028] S303: Based on the sensor installation and test configuration, continuous monitoring of dressing use environment changes is performed, including continuous recording of temperature, humidity and pH value, and monitoring data is collected and stored to obtain an environmental monitoring sensor network.
[0029] As a further solution of the present invention, the environmental monitoring sensor network is applied with a long short-term memory network to analyze the performance changes of the dressing under different usage environments, identify the key factors affecting the drug release rate and the air permeability of the dressing, and obtain the dressing performance change analysis results in the following steps:
[0030] S401: Arranging the time series of temperature, humidity and pH value changes according to the data collected by the environmental monitoring sensor network, preparing the data format and structure for analysis, and obtaining a time series data set;
[0031] S402: Based on the time series data set, screen the time periods and environmental conditions that significantly affect the performance change of the dressing, and mark the data points to reveal key observation areas, and obtain a key data mark set;
[0032] S403: Based on the key data tag set, a long short-term memory network is used to identify environmental change factors that affect the drug release rate and air permeability in the dressing, summarize the manner and degree of influence of the factors on the dressing performance, and obtain the dressing performance change analysis results;
[0033] The long short-term memory network is based on the formula:
[0034]
[0035] Calculate the update of cell state and accurately generate analysis results of dressing performance changes, including:
[0036] C t is the state at time step t, f t is the activation value of the forget gate, C t-1 is the state of the previous time step, i t is the activation value of the input gate, E s tability is the environmental stability coefficient, Tm odulation is the time adjustment factor, D c haracteristics is the drug characteristic coefficient M p Permeability is the air permeability index of dressing materials. c is the weight matrix, b c is the bias term, [h t-1 ,x t ] is the combination of the input of the current time step and the hidden state of the previous time step, and | is element-wise multiplication.
[0037] As a further solution of the present invention, according to the analysis results of the performance change of the dressing, the wrapping material is selected, the medicinal ingredients are encapsulated, the stability under different conditions is tested, the service life of the drug is optimized and extended, and the steps of obtaining the stability adjustment plan of the medicinal ingredients are as follows:
[0038] S501: Based on the analysis results of the dressing performance changes, selecting wrapping materials with strong antioxidant and moisture resistance, including polyvinyl alcohol and polylactic acid, to provide physical and chemical protection for the traditional Chinese medicine components, and generating wrapping material screening results;
[0039] S502: Based on the packaging material screening results, the selected packaging materials are applied to the traditional Chinese medicine components, and the stability of the encapsulated medicinal components under high temperature, high humidity and acid-base change conditions is evaluated through small batch tests to obtain packaging stability test data;
[0040] S503: Based on the packaging stability test data, optimize the usage ratio of the packaging materials and the packaging process to ensure the stable release of the active ingredient under the worst usage environment and obtain a stability adjustment plan for the active ingredient.
[0041] As a further solution of the present invention, based on the stability adjustment scheme of the active ingredient, the internal flow field design of the microfluidic chip is optimized, the flow field layout is adjusted, the drug distribution and release rate are tested, and the drug release control optimization scheme is obtained to meet the treatment needs.
[0042] S601: Based on the stability adjustment scheme of the active ingredient, the internal flow field design of the microfluidic chip is optimized, and the ideal distribution pattern of the drug in the flow field is determined in combination with the physical and chemical properties of the drug and the treatment needs, and a flow field optimization map is generated;
[0043] S602: According to the flow field optimization diagram, an experimental platform is built to experimentally test the distribution and release rate of the drug in the microfluidic chip, record the drug release efficiency under different layouts, and obtain drug release experimental data;
[0044] S603: According to the drug release experimental data, the layout of the flow field inside the microfluidic chip is adjusted to optimize the drug distribution and release rate to ensure that the treatment needs are met and obtain a drug release control optimization plan.
[0045] A Chinese medicine external application treatment system, the system comprising a matrix material screening module, a microchannel design module, an environmental monitoring module, a performance analysis module, a drug efficacy encapsulation module, a flow field optimization module, and a drug release control module;
[0046] The matrix material screening module screens natural polymer materials and synthetic polymers based on the chemical stability of traditional Chinese medicine ingredients and the skin's absorption requirements for drugs, and generates matrix material screening results based on the air permeability and absorbency of the materials;
[0047] The microchannel design module performs preliminary design of the microchannel based on the matrix material screening results, and adjusts the width and length of the microchannel in combination with the viscosity and fluidity requirements of the drug to ensure that the drug can be evenly distributed and effectively released, thereby obtaining a microchannel design scheme;
[0048] The environmental monitoring module is based on a microchannel design scheme, and temperature, humidity and pH sensors are installed on the dressing to collect data on changes in the dressing use environment, conduct continuous real-time monitoring, and generate an environmental monitoring data set;
[0049] The performance analysis module uses a time series analysis method based on the environmental monitoring data set to screen out the key time periods and environmental conditions that affect the drug release rate and the air permeability of the dressing, summarize the changing rules of the dressing performance, and obtain the dressing performance change analysis results;
[0050] The drug efficacy encapsulation module selects a wrapping material with anti-oxidation and anti-moisture properties based on the dressing performance change analysis results, performs protective encapsulation on the drug efficacy components, tests the stability of the encapsulation material under different conditions, and generates a drug efficacy component stability adjustment plan;
[0051] The flow field optimization module adjusts the internal flow field design of the microfluidic chip based on the stability adjustment scheme of the active ingredient, adjusts the flow field layout using experimental testing methods, ensures the distribution and release of the drug as required, and generates flow field layout optimization results;
[0052] The drug release control module performs a final drug release control test based on the flow field layout optimization result, verifies through experiments whether the distribution and release rate of the drug on the skin meet the treatment requirements, ensures the treatment effect of the dressing, and obtains a drug release control optimization plan.
[0053] Compared with the prior art, the advantages and positive effects of the present invention are: In the present invention, by adjusting the microchannel structure through microfluidic technology, it is possible to achieve precise matching of drug release rate and path, ensure that the Chinese medicine ingredients can reach the target site evenly and effectively according to treatment needs, make the distribution of the drug in the dressing more balanced, and improve the consistency and predictability of the treatment effect. At the same time, the configuration of temperature, humidity and pH sensors and the combination of long-short-term memory network analysis provide real-time monitoring and adaptive adjustment of the performance of the dressing in different environments, significantly improve the responsiveness of the dressing to environmental changes, and ensure that the optimal treatment effect can be maintained under various conditions of use. BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 It is a schematic diagram of the workflow of the present invention; Figure 2 This is a detailed flow chart of S1 of the present invention; Figure 3 This is a detailed flow chart of S2 of the present invention; Figure 4 This is a detailed flow chart of S3 of the present invention; Figure 5 This is a detailed flow chart of S4 of the present invention; Figure 6 This is a detailed flow chart of S5 of the present invention; Figure 7 This is a detailed flow chart of S6 of the present invention; Figure 8 It is a system flow chart of the present invention. DETAILED DESCRIPTION
[0063] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the accompanying drawings and embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not intended to limit the present invention.
[0064] In the description of the present invention, it should be understood that the terms "length", "width", "up", "down", "front", "back", "left", "right", "vertical", "horizontal", "top", "bottom", "inside", "outside" and the like indicate positions or positional relationships based on the positions or positional relationships shown in the drawings, and are only for the convenience of describing the present invention and simplifying the description, rather than indicating or implying that the device or element referred to must have a specific orientation, be constructed and operated in a specific orientation, and therefore cannot be understood as limiting the present invention. In addition, in the description of the present invention, "multiple" means two or more, unless otherwise clearly and specifically defined.
[0065] Embodiment 1
[0066] See also Figure 1 The present invention provides a technical solution: a method for treating external application of traditional Chinese medicine, comprising the following steps:
[0067] S1: Select appropriate matrix materials, design dressings based on the characteristics of Chinese medicine ingredients and skin permeability requirements, test the effect of the matrix on drug release, and obtain a dressing matrix design plan;
[0068] S2: Based on the dressing matrix design, use microfluidics technology to adjust the structure of the microchannel in the dressing, match the optimal release rate and path of the Chinese medicine ingredients, simulate the flow of drugs in the microchannel, optimize and match the drug release requirements, and generate a microchannel structure adjustment plan;
[0069] S3: Using the microchannel structure adjustment scheme, configure temperature, humidity and pH sensors to record changes in the dressing use environment and collect data to obtain an environmental monitoring sensor network;
[0070] S4: The environmental monitoring sensor network is used to apply the long short-term memory network to analyze the performance changes of the dressing under different usage environments, identify the key factors affecting the drug release rate and the air permeability of the dressing, and obtain the analysis results of the dressing performance changes;
[0071] S5: According to the results of the dressing performance change analysis, select the wrapping material, encapsulate the active ingredients, test the stability under different conditions, optimize and extend the service life of the drug, and obtain the stability adjustment plan of the active ingredients;
[0072] S6: Based on the stability adjustment plan of the active ingredient, optimize the internal flow field design of the microfluidic chip, adjust the flow field layout, test the drug distribution and release rate, meet the treatment needs, and obtain the drug release control optimization plan.
[0073] The dressing matrix design scheme includes the use of natural fibers, synthetic polymer materials and breathable adhesives. The microchannel structure adjustment scheme specifically includes adjusting the width and length of the microchannel and the type of coating on the inner wall of the microchannel. The environmental monitoring sensor network includes skin contact temperature monitoring sensors, humidity monitoring sensors and pH monitoring sensors. The dressing performance change analysis results include the air permeability data of the dressing under different humidity conditions and the drug release rate data under different temperatures. The active ingredient stability adjustment scheme includes the use of antioxidant coating materials, photosensitizers and humidity controllers. The drug release control optimization scheme includes the adjustment of drug distribution uniformity, the release rate increment level and the optimization and adjustment of the adhesion between the dressing and the skin.
[0074] See also Figure 2 , select appropriate matrix materials, combine the characteristics of traditional Chinese medicine ingredients and skin permeability requirements, design dressings, test the effect of the matrix on drug release, and obtain the steps of dressing matrix design scheme:
[0075] S101: Select appropriate matrix materials, combine the chemical stability of Chinese medicine ingredients and the skin's absorption requirements for drugs, screen natural polymer materials and synthetic polymers with good air permeability and absorption performance, conduct preliminary dressing matrix ratio experiments, and obtain preliminary matrix material selection results;
[0076] In step S101, a suitable matrix material is selected, and the chemical stability of the Chinese medicine ingredients and the skin's absorption requirements for the drug are combined. A material performance evaluation program is used, and material screening simulation is performed using MATLAB. The input parameters include the material's air permeability coefficient, absorption rate, and chemical stability index. The execution operations include scoring and ranking each material, prioritizing them according to the characteristics of the Chinese medicine ingredients and skin requirements, conducting preliminary dressing matrix ratio experiments, and generating preliminary matrix material selection results.
[0077] S102: Based on the preliminary results of matrix materials, the selected materials are tested for chemical and physical properties, including air permeability, hygroscopicity and drug release properties, the test data of the materials are compared, the matrix materials with the best characteristics of traditional Chinese medicine ingredients are identified, and the matrix material screening and refinement results are generated;
[0078] In step S102, based on the preliminary selection results of the matrix material, the physical and chemical experimental analysis method is adopted, and the spectrometer and the air permeability testing device are used to experimentally measure the air permeability, hygroscopicity and drug release performance of the selected material. The parameter settings include the temperature and humidity range, test duration, and drug concentration. After the measurement operation is performed, the data is sorted and compared and analyzed through Excel to identify the matrix material suitable for the characteristics of the traditional Chinese medicine ingredients and generate the matrix material screening and refinement results.
[0079] S103: Based on the screening and refinement results of matrix materials, combined with the characteristics of traditional Chinese medicine ingredients and the breathability requirements of the skin, the influence of the matrix on drug release is tested, and the release efficiency and duration of the drug are optimized by adjusting the material ratio and hierarchical structure to obtain a dressing matrix design scheme;
[0080] In step S103, based on the results of matrix material screening and refinement, a drug release dynamic simulation system is used to set simulation parameters including temperature and humidity of the release environment, pH value, and dressing thickness in combination with the characteristics of the Chinese medicine ingredients and the skin's breathability requirements. The simulation operation includes adjusting the dressing material ratio and structural hierarchy, and optimizing the drug release efficiency and duration by dynamically monitoring the distribution and absorption of the drug on the simulated skin surface to obtain a dressing matrix design solution.
[0081] See also Figure 3 Based on the dressing matrix design, the microfluidic technology is used to adjust the structure of the microchannel in the dressing, match the optimal release rate and path of the Chinese medicine ingredients, simulate the flow of drugs in the microchannel, optimize and match the drug release requirements, and generate the microchannel structure adjustment plan.
[0082] S201: Based on the dressing matrix design, the microfluidics technology is used to draw a preliminary design of the microchannel. Combined with the physical properties of the Chinese medicine ingredients, including viscosity and fluidity, the preliminary width and length of the microchannel are determined to generate a preliminary design of the microchannel;
[0083] Microfluidics technology, according to the formula:
[0084]
[0085] Calculate the flow rate of the microchannel and generate a preliminary design diagram of the microchannel, where Q is the flow rate (volume per unit time), which reflects the flow rate of the Chinese medicine ingredients in the microchannel, ΔP is the pressure difference, the pressure difference at both ends of the microchannel is the main factor driving the fluid flow, d is the diameter of the microchannel (for non-circular channels, use the equivalent diameter), which affects the flow rate and flow of the fluid, n is the non-Newtonian behavior index, which describes the relationship between the fluidity of the Chinese medicine ingredient fluid and the shear rate, indicating whether and how the fluid deviates from the behavior of the Newtonian fluid, T vis is the coefficient of temperature on viscosity, reflecting the sensitivity of the viscosity of the Chinese medicine component to temperature changes, and is used to adjust the viscosity value to adapt to the actual situation under different temperature conditions. μ is the dynamic viscosity, which measures the internal resistance of the Chinese medicine component fluid during flow. L is the length of the microchannel, which directly affects the flow resistance and required pressure difference of the fluid in the microchannel. S shape is the shape coefficient, which reflects the effect of microchannel shape on fluid flow and is used to adjust the flow calculation of non-circular microchannels to ensure that the formula is applicable to a variety of microchannel shapes.
[0086] The execution process is as follows:
[0087] Physical properties and rheological evaluation, viscosity μ was measured for TCM ingredients and its change with temperature was evaluated to determine T vis At the same time, rheological experiments were performed to determine whether the Chinese medicine components behaved as non-Newtonian fluids and the corresponding non-Newtonian behavior index n;
[0088] Microchannel design parameters are determined, and the shape factor S is estimated based on the predetermined shape and size of the microchannel. shape ;
[0089] Parameter calculation and optimization: using known physical properties and design parameters, the ideal microchannel dimensions (diameter d and length L) are calculated through improved formulas to achieve the expected flow rate Q and drug delivery performance;
[0090] Design verification and adjustment: preliminary drawing of the microchannel design is carried out based on the calculation results, and the effectiveness of the design is verified through experiments or simulations. At the same time, adjustments can be made based on feedback to optimize the design.
[0091] Through this method, microchannels suitable for Chinese medicine ingredients can be more accurately calculated and designed to ensure effective drug delivery and the ultimate efficacy of the dressing. The introduction of the improved formula can provide higher adaptability and accuracy, making the microchannel design more in line with the needs of practical applications.
[0092] S202: Based on the preliminary design drawing of the microchannel, a simulation test of drug flow in the microchannel is performed, the size of the microchannel is adjusted to ensure that the Chinese medicine ingredients can be evenly diffused on the simulated skin surface, and a microchannel size adjustment plan is generated;
[0093] In step S202, based on the preliminary design drawing of the microchannel, the finite element analysis (FEA) method is used to set the microchannel size adjustment as the objective function, and the diffusion effect of the traditional Chinese medicine ingredients on the simulated skin surface is considered as a constraint condition. The size optimization algorithm is executed to adjust the microchannel width and length parameters to achieve the goal of uniform diffusion. The simulation test data is used for verification to confirm that the drug can diffuse evenly on the simulated skin surface, and a microchannel size adjustment plan is generated.
[0094] S203: Based on the microchannel size adjustment plan, the microchannel structure is optimized to match the optimal release rate and path of the Chinese medicine ingredients, and an actual drug release test is performed to confirm the flow and release efficiency of the drug in the microchannel, and a microchannel structure adjustment plan is obtained;
[0095] In step S203, based on the microchannel size adjustment plan, an experimental verification method is adopted, the microchannel structure and the release rate of the traditional Chinese medicine ingredients are set as variables, and an actual drug release test is performed. The concentration of the drug at the microchannel outlet is measured using high-performance liquid chromatography (HPLC) technology. By comparing the experimental data with the treatment needs, the microchannel structure parameters are adjusted to ensure that the drug release efficiency and rate meet the treatment needs, and a microchannel structure adjustment plan is generated.
[0096] See also Figure 4 ,Using the microchannel structure adjustment scheme, configuring temperature, humidity and pH sensors, recording the changes in the dressing use environment, and collecting data, the steps of obtaining the environmental monitoring sensor network are,
[0097] S301: According to the microchannel structure adjustment plan, a temperature sensor, a humidity sensor, and a pH sensor are selected, and the placement and quantity of the sensors are determined to cover the key use area of the dressing, and a sensor layout plan is obtained;
[0098] In step S301, according to the microchannel structure adjustment plan, digital temperature sensors, digital humidity sensors and pH electrode sensors suitable for microenvironment monitoring are selected, and dressing surface distribution simulation is adopted. The sensor distribution algorithm is written in Python. The input parameters include dressing area, expected number of monitoring points, and release area of traditional Chinese medicine ingredients. The algorithm is executed to automatically calculate the optimal placement position and number of sensors to ensure full coverage of the key use areas of the dressing and generate a sensor layout plan.
[0099] S302: Based on the sensor layout plan, install sensors in the dressing, connect data transmission lines, conduct preliminary environmental monitoring tests, adjust the sensitivity and response time of the sensors, and generate sensor installation and test configurations;
[0100] In step S302, based on the sensor layout plan, the sensor is manually installed in the dressing, and the data transmission line is connected using the Arduino development board. The sensor data acquisition and preliminary analysis program is written. The input parameter settings include the sampling frequency of 100 Hz, the data transmission rate of 9600 bps, and the environmental monitoring threshold. When executing the program, the sensitivity and response time of the sensor are debugged on the spot, preliminary environmental monitoring data are collected, and a rapid feasibility verification is performed to generate the sensor installation and test configuration.
[0101] S303: Based on the sensor installation and test configuration, continuous dressing use environment change monitoring is performed, including continuous recording of temperature, humidity and pH value, and monitoring data is collected and stored to obtain an environmental monitoring sensor network;
[0102] In step S303, based on the sensor installation and test configuration, the Internet of Things (IoT) platform is used for data management, and the continuous monitoring mode of environmental parameters is set. The input parameters include the temperature range of -20°C to 60°C, the humidity range of 10% to 90% RH, and the pH value range of 1 to 14. The data collection task is performed, and the data storage and processing capabilities of the IoT platform are used to automatically record the changes in temperature, humidity, and pH value, perform long-term data accumulation, and generate an environmental monitoring sensor network.
[0103] See also Figure 5 ,The environmental monitoring sensor network is used to analyze the performance changes of dressings under different usage environments using long short-term memory networks, and the key factors affecting the drug release rate and the air permeability of the dressings are identified. The steps to obtain the analysis results of the dressing performance changes are as follows:
[0104] S401: Based on the data collected by the environmental monitoring sensor network, the time series of temperature, humidity and pH value changes are sorted, and the data format and structure are prepared for analysis to obtain a time series data set;
[0105] In step S401, based on the data collected by the environmental monitoring sensor network, Python is used to write a script to process the data, and the changes in temperature, humidity and pH value are processed in time series. The Pandas library is used to format the data, and the time window is set to one data point every 30 minutes. Data cleaning is performed, outliers are removed, and normalization is performed to prepare a data format and structure suitable for long short-term memory network (LSTM) analysis to obtain a time series data set.
[0106] S402: Based on the time series data set, screen the time periods and environmental conditions that have a significant impact on the performance changes of the dressings, and mark the data points to reveal the key observation areas and obtain the key data mark set;
[0107] In step S402, based on the time series data set, feature selection was performed using Python's Scikit-learn library, and the mutual information method was used to evaluate the effects of temperature, humidity, and pH on dressing performance in each time period. The screening threshold was set to the upper quartile of the information gain, and data points with information gain higher than this threshold were marked as key observation areas. The feature selection algorithm was executed to identify the environmental conditions with the strongest correlation with dressing performance changes, and a key data marker set was generated.
[0108] S403: Based on the key data marker set, the long short-term memory network is used to identify the environmental change factors that affect the drug release rate and air permeability in the dressing, summarize the way and degree of influence of the factors on the dressing performance, and obtain the dressing performance change analysis results;
[0109] Long short-term memory network, according to the formula:
[0110]
[0111] Calculate the update of cell state and accurately generate analysis results of dressing performance changes, including:
[0112] C t is the state at time step t, representing the internal state of the LSTM network at the current time point, f t is the activation value of the forget gate, which determines how much information of the previous state is retained. t-1 is the state of the previous time step, representing the internal state of the LSTM network at the previous time point, i t is the activation value of the input gate, which determines how much new input information is added to the cell state. s Tability is the environmental stability coefficient, which quantifies the impact of the stability of environmental changes on the performance of the dressing. m odulation is the time adjustment factor, which reflects the regulatory effect of time changes on dressing performance. characteristics is the drug characteristic coefficient, which takes into account the effect of the chemical properties of the drug itself on the release rate. p Permeability is an index of the air permeability of dressing materials, which quantifies the effect of the air permeability of dressings on drug release and air permeability. c is the weight matrix used to control the contribution of the current input and the previous hidden state to the cell state update, b c is a bias term used to adjust the activation threshold during cell state update, [h t-1 ,x t ] is the combination of the input of the current time step and the hidden state of the previous time step, which provides the model with the ability to process sequence data, and | is element-by-element multiplication.
[0113] The execution process is as follows:
[0114] Parametric data preprocessing to quantify the factors affecting the performance of the dressing, and conduct extensive data analysis and experimental testing to determine the values of the four creative parameters;
[0115] Model design and training,In the LSTM network design stage, parameters are incorporated into the network as inputs or adjustment factors.,Parameters directly affect the learning process of the network, enabling the network to better understand and predict the dynamics of dressing performance as the environment changes;
[0116] Model optimization and verification: verify the model's prediction results through experimental data, compare with the baseline model, and adjust parameter values to optimize model performance;
[0117] Performance analysis: Use the trained model to predict new environmental data to analyze and summarize the impact of environmental change factors on dressing performance.
[0118] By improving the execution process of the formula and detailed explanation of the parameters, we can more deeply and accurately predict and analyze the impact of environmental changes on the drug release rate and permeability in dressings, greatly improving the prediction accuracy of the model.
[0119] See also Figure 6 According to the analysis results of dressing performance changes, the wrapping material is selected, the medicinal ingredients are encapsulated, the stability under different conditions is tested, the service life of the drug is optimized and extended, and the steps for obtaining the stability adjustment plan of the medicinal ingredients are as follows:
[0120] S501: Based on the analysis results of dressing performance changes, select wrapping materials with strong antioxidant and moisture resistance, including polyvinyl alcohol and polylactic acid, to provide physical and chemical protection for traditional Chinese medicine ingredients and generate wrapping material screening results;
[0121] In step S501, based on the analysis results of dressing performance changes, a material compatibility test method is adopted, and a high performance liquid chromatography (HPLC) is used to analyze the chemical stability of polyvinyl alcohol (PVA) and polylactic acid (PLA). The input parameters include solvent type, temperature, and test time. The operations performed include testing the solubility of the solvent in the material and testing the stability of the material under different pH conditions. The obtained HPLC spectrum is analyzed to evaluate the antioxidant and moisture resistance of the material, and generate a wrapping material screening result.
[0122] S502: Based on the packaging material screening results, the selected packaging materials are applied to the Chinese medicine ingredients, and the stability of the encapsulated medicinal ingredients under high temperature, high humidity and acid-base change conditions is evaluated through small batch tests to obtain packaging stability test data;
[0123] In step S502, based on the screening results of packaging materials, encapsulation technology is applied, and a micro-encapsulation machine is used to encapsulate the medicinal ingredients. The setting parameters include a packaging temperature of 60°C, a packaging pressure of 5 MPa, and a packaging time of 10 minutes. The operations include mixing the medicinal ingredients with the selected packaging materials, performing micro-encapsulation treatment, and testing the stability of the encapsulated samples under high temperature, high humidity and different pH conditions by differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA) to generate packaging stability test data.
[0124] S503: Based on the packaging stability test data, optimize the usage ratio of the packaging materials and the packaging process to ensure the stable release of the active ingredients under the worst use environment and obtain a stability adjustment plan for the active ingredients;
[0125] In step S503, based on the packaging stability test data, a process optimization strategy is adopted to adjust the packaging material ratio and packaging parameters in the micro-encapsulation process. The input parameter adjustment includes lowering the packaging temperature to 55°C and increasing the packaging pressure to 6MPa. The execution operation includes re-micro-encapsulation processing and testing the performance of the improved packaging samples under extreme environmental conditions. By comparing the original and optimized stability test data, it is ensured that the active ingredients can be stably released under adverse conditions, and a stability adjustment plan for the active ingredients is generated.
[0126] See also Figure 7 Based on the stability adjustment plan of the active ingredient, the internal flow field design of the microfluidic chip is optimized, the flow field layout is adjusted, the drug distribution and release rate are tested, and the steps for obtaining the drug release control optimization plan to meet the treatment needs are as follows:
[0127] S601: Based on the stability adjustment plan of the active ingredient, optimize the internal flow field design of the microfluidic chip, combine the physical and chemical properties of the drug and the treatment needs, determine the ideal pattern of drug distribution in the flow field, and generate the flow field optimization map;
[0128] In step S601, based on the stability adjustment plan of the active ingredient, computational fluid dynamics (CFD) analysis is adopted, and ANSYS Fluent software is used to simulate the internal flow field of the microfluidic chip. The input parameters include the density, viscosity, surface tension of the drug, and the flow rate and temperature defined by the treatment needs. The flow field simulation operation includes setting boundary conditions, meshing and solver configuration. The flow pattern and distribution state of the drug in the microfluidic chip are obtained through iterative calculation to ensure that the flow field layout conforms to the optimal mode of drug release and distribution, and generate a flow field optimization diagram.
[0129] S602: According to the flow field optimization diagram, an experimental platform is built to experimentally test the distribution and release rate of the drug in the microfluidic chip, record the drug release efficiency under different layouts, and obtain drug release experimental data;
[0130] In step S602, a drug release experimental platform is built according to the flow field optimization diagram, and the experimental rheology method is used to set the part of the microfluidic chip that contacts the drug as the test area. The input parameters for adjustment include the microchannel inlet velocity, chip temperature and pH value. The operations performed include loading the drug through the microchannel, determining the release rate and observing the drug distribution. The particle image velocimetry technology is used to record the distribution of the drug in the microfluidic chip, and the changes in drug release efficiency under different flow field layouts are analyzed to generate drug release experimental data.
[0131] S603: According to the drug release experimental data, the layout of the flow field inside the microfluidic chip is adjusted to optimize the drug distribution and release rate to ensure that the treatment needs are met and obtain the drug release control optimization plan;
[0132] In step S603, according to the drug release experimental data, an optimization design method is adopted and MATLAB is used to perform parameter optimization. The input parameters include the geometric parameters of the internal flow field layout of the microfluidic chip, the target rate of drug release and the distribution uniformity. The execution operation includes adjusting the internal structural parameters of the microfluidic chip, such as the width, length and branch structure of the microchannel. By comparing the drug release data before and after optimization, the flow field layout is adjusted to achieve the predetermined drug release rate and therapeutic effect, ensuring that the drug distribution and release rate meet the treatment needs, and generating a drug release control optimization plan.
[0133] See also Figure 8 , a Chinese medicine external application treatment system includes a matrix material screening module, a microchannel design module, an environmental monitoring module, a performance analysis module, a drug efficacy encapsulation module, a flow field optimization module, and a drug release control module;
[0134] The matrix material screening module screens natural polymer materials and synthetic polymers based on the chemical stability of traditional Chinese medicine ingredients and the skin's absorption requirements for drugs, and generates matrix material screening results based on the material's air permeability and absorbency;
[0135] The microchannel design module conducts preliminary design of the microchannel based on the matrix material screening results, and adjusts the width and length of the microchannel in combination with the viscosity and fluidity requirements of the drug to ensure that the drug can be evenly distributed and effectively released, thus obtaining a microchannel design solution;
[0136] The environmental monitoring module is based on a microchannel design solution. Temperature, humidity and pH sensors are installed on the dressing to collect data on changes in the dressing use environment, conduct continuous real-time monitoring, and generate an environmental monitoring data set.
[0137] The performance analysis module uses time series analysis methods based on environmental monitoring data sets to screen out the key time periods and environmental conditions that affect drug release rate and dressing air permeability, summarize the changing patterns of dressing performance, and obtain dressing performance change analysis results;
[0138] Based on the analysis results of dressing performance changes, the drug encapsulation module selects packaging materials with antioxidant and moisture-resistant properties to protect the drug ingredients, tests the stability of the packaging materials under different conditions, and generates a stability adjustment plan for the drug ingredients;
[0139] The flow field optimization module adjusts the internal flow field design of the microfluidic chip based on the stability adjustment plan of the active ingredient, and uses experimental testing methods to adjust the flow field layout to ensure that the drug is distributed and released as needed, and generates flow field layout optimization results;
[0140] The drug release control module conducts the final drug release control test based on the flow field layout optimization results. It verifies through experiments whether the distribution and release rate of the drug on the skin meet the treatment requirements, ensures the therapeutic effect of the dressing, and obtains the drug release control optimization plan.
[0141] The above are only preferred embodiments of the present invention and are not intended to limit the present invention in other forms. Any technician familiar with the profession may use the technical contents disclosed above to change or modify them into equivalent embodiments with equivalent changes and apply them to other fields. However, any simple modification, equivalent change and modification made to the above embodiments based on the technical essence of the present invention without departing from the technical solution of the present invention still falls within the protection scope of the technical solution of the present invention.
Claims
1. A method of external application of traditional Chinese medicine, characterized in that: The following steps are included: Select appropriate matrix materials, design dressings based on the characteristics of Chinese medicine ingredients and skin permeability requirements, test the effect of the matrix on drug release, and obtain a dressing matrix design plan; Based on the dressing matrix design scheme, the microfluidic technology is used to adjust the structure of the microchannel in the dressing, match the optimal release rate and path of the traditional Chinese medicine ingredients, simulate the flow of the drug in the microchannel, optimize and match the drug release requirements, and generate a microchannel structure adjustment scheme; Using the microchannel structure adjustment scheme, configuring temperature, humidity and pH sensors, recording changes in the dressing use environment, and collecting data to obtain an environmental monitoring sensor network; The environmental monitoring sensor network is applied with a long short-term memory network to analyze the performance changes of the dressing under different usage environments, identify the key factors affecting the drug release rate and the air permeability of the dressing, and obtain the analysis results of the dressing performance changes; According to the analysis results of the dressing performance changes, the wrapping material is selected, the medicinal ingredients are encapsulated, the stability under different conditions is tested, the service life of the drug is optimized and extended, and a stability adjustment plan for the medicinal ingredients is obtained; Based on the stability adjustment plan of the active ingredient, the internal flow field design of the microfluidic chip is optimized, the flow field layout is adjusted, the drug distribution and release rate are tested to meet the treatment needs, and the drug release control optimization plan is obtained.
2. The method of external application of traditional Chinese medicine according to claim 1, characterized in that: The dressing matrix design scheme includes the use of natural fibers, synthetic polymer materials and breathable adhesives. The microchannel structure adjustment scheme specifically adjusts the width and length of the microchannel and the type of coating on the inner wall of the microchannel. The environmental monitoring sensor network includes a skin contact temperature monitoring sensor, a humidity monitoring sensor and a pH value monitoring sensor. The dressing performance change analysis results specifically include the air permeability data of the dressing under different humidity conditions and the data of the drug release rate at different temperatures. The active ingredient stability adjustment scheme includes the use of antioxidant coating materials, photosensitizers and humidity control agents. The drug release control optimization scheme specifically includes the adjustment of drug distribution uniformity, the release rate increment level and the optimization adjustment of the dressing to the skin.
3. The method for external application of traditional Chinese medicine according to claim 1, characterized in that: The steps of selecting appropriate matrix materials, designing dressings based on the characteristics of Chinese medicine ingredients and the breathability requirements of the skin, and testing the effect of the matrix on drug release are as follows: Select appropriate matrix materials, combine the chemical stability of Chinese medicine ingredients and the skin's absorption requirements for drugs, screen natural polymer materials and synthetic polymers with good air permeability and absorption performance, conduct preliminary dressing matrix ratio experiments, and obtain preliminary matrix material selection results; Based on the preliminary selection results of the matrix materials, the selected materials are tested for chemical and physical properties, including air permeability, hygroscopicity and drug release performance, the test data of the materials are compared, the matrix materials with the best characteristics of the traditional Chinese medicine ingredients are identified, and the matrix material screening and refinement results are generated; According to the screening and refinement results of the matrix material, combined with the characteristics of the traditional Chinese medicine ingredients and the skin permeability requirements, the effect of the matrix on drug release was tested, and the release efficiency and duration of the drug were optimized by adjusting the material ratio and hierarchical structure to obtain a dressing matrix design solution.
4. The method of external application of traditional Chinese medicine according to claim 1, characterized in that: Based on the dressing matrix design scheme, the microfluidic technology is used to adjust the structure of the microchannel in the dressing, match the optimal release rate and path of the traditional Chinese medicine ingredients, simulate the flow of the drug in the microchannel, optimize and match the drug release requirements, and generate the microchannel structure adjustment scheme in the following steps: Based on the dressing matrix design scheme, a preliminary design diagram of the microchannel is drawn using microfluidics technology, and the preliminary width and length of the microchannel are determined in combination with the physical properties of the Chinese medicine ingredients, including viscosity and fluidity, to generate a preliminary design diagram of the microchannel; Based on the preliminary design of the microchannel, a simulation test of drug flow in the microchannel is conducted, the size of the microchannel is adjusted to ensure that the Chinese medicine ingredients can be evenly diffused on the simulated skin surface, and a microchannel size adjustment plan is generated; Based on the microchannel size adjustment scheme, the microchannel structure is optimized, the optimal release rate and path of the traditional Chinese medicine ingredients are matched, actual drug release tests are carried out, the flow and release efficiency of the drug in the microchannel are confirmed, and the microchannel structure adjustment scheme is obtained.
5. The method of external application of traditional Chinese medicine according to claim 1, characterized in that: The steps of using the microchannel structure adjustment scheme, configuring temperature, humidity and pH sensors, recording changes in the dressing use environment, and collecting data to obtain an environmental monitoring sensor network are as follows: According to the microchannel structure adjustment scheme, temperature sensors, humidity sensors and pH sensors are selected, the placement and quantity of the sensors are determined, the key use areas of the dressing are covered, and a sensor layout plan is obtained; Based on the sensor layout plan, install sensors in the dressing, connect data transmission lines, conduct preliminary environmental monitoring tests, adjust sensor sensitivity and response time, and generate sensor installation and test configurations; Based on the sensor installation and test configuration, continuous dressing environment change monitoring is performed, including continuous recording of temperature, humidity and pH value, and monitoring data is collected and stored to obtain an environmental monitoring sensor network.
6. The method of external application of traditional Chinese medicine according to claim 1, characterized in that: The environmental monitoring sensor network is applied with a long short-term memory network to analyze the performance changes of the dressing under different use environments, identify the key factors affecting the drug release rate and the air permeability of the dressing, and obtain the dressing performance change analysis results in the following steps: Based on the data collected by the environmental monitoring sensor network, the time series of temperature, humidity and pH value changes are sorted, and the data format and structure are prepared for analysis to obtain a time series data set; Based on the time series data set, the time periods and environmental conditions that significantly affect the performance changes of the dressings are screened, and the data points are marked to reveal key observation areas, thereby obtaining a key data marking set; Based on the key data marker set, a long short-term memory network is used to identify environmental change factors that affect the drug release rate and air permeability in the dressing, summarize the way and degree of influence of the factors on the dressing performance, and obtain the dressing performance change analysis results; The long short-term memory network is based on the formula: Calculate the update of cell state and accurately generate analysis results of dressing performance changes, including: C t is the state at time step t, f t is the activation value of the forget gate, C t-1 is the state of the previous time step, i t is the activation value of the input gate, E s tability is the environmental stability coefficient, T m odulation is the time adjustment factor, D c haracteristics is the drug characteristic coefficient M p Permeability is the air permeability index of dressing materials. c is the weight matrix, b c is the bias term, [h t-1 ,x t ] is the combination of the input of the current time step and the hidden state of the previous time step, and | is element-wise multiplication.
7. The method of external application of traditional Chinese medicine according to claim 1, characterized in that: According to the analysis results of the dressing performance changes, the wrapping material is selected, the medicinal ingredients are encapsulated, the stability under different conditions is tested, the service life of the drug is optimized and extended, and the steps of obtaining the medicinal ingredient stability adjustment plan are as follows: Based on the analysis results of the dressing performance changes, a wrapping material with strong antioxidant and moisture resistance is selected, including polyvinyl alcohol and polylactic acid, to provide physical and chemical protection for the Chinese medicine components, and a wrapping material screening result is generated; Based on the packaging material screening results, the selected packaging materials are applied to the traditional Chinese medicine ingredients, and the stability of the encapsulated medicinal ingredients under high temperature, high humidity and acid-base change conditions is evaluated through small batch tests to obtain packaging stability test data; Based on the packaging stability test data, the usage ratio of the packaging material and the packaging process are optimized to ensure the stable release of the active ingredient under the worst usage environment, and to obtain a stability adjustment plan for the active ingredient.
8. The method of external application of traditional Chinese medicine according to claim 1, characterized in that: Based on the stability adjustment scheme of the active ingredient, the steps of optimizing the internal flow field design of the microfluidic chip, adjusting the flow field layout, testing the drug distribution and release rate, and meeting the treatment needs to obtain the drug release control optimization scheme are as follows: Based on the stability adjustment scheme of the active ingredient, the internal flow field design of the microfluidic chip is optimized, and the ideal mode of drug distribution in the flow field is determined in combination with the physical and chemical properties of the drug and the treatment needs, and a flow field optimization map is generated; According to the flow field optimization diagram, an experimental platform is built to test the distribution and release rate of the drug in the microfluidic chip, record the drug release efficiency under different layouts, and obtain drug release experimental data; According to the drug release experimental data, the layout of the flow field inside the microfluidic chip is adjusted to optimize the drug distribution and release rate to ensure that the treatment needs are met and obtain an optimized drug release control solution.
9. A Chinese medicine external application treatment system, characterized in that: According to a traditional Chinese medicine external application treatment method according to any one of claims 1 to 8, the system comprises a matrix material screening module, a microchannel design module, an environmental monitoring module, a performance analysis module, a drug efficacy encapsulation module, a flow field optimization module, and a drug release control module; The matrix material screening module screens natural polymer materials and synthetic polymers based on the chemical stability of traditional Chinese medicine ingredients and the skin's absorption requirements for drugs, and generates matrix material screening results based on the air permeability and absorbency of the materials; The microchannel design module performs preliminary design of the microchannel based on the matrix material screening results, and adjusts the width and length of the microchannel in combination with the viscosity and fluidity requirements of the drug to ensure that the drug can be evenly distributed and effectively released, thereby obtaining a microchannel design scheme; The environmental monitoring module is based on a microchannel design scheme, and temperature, humidity and pH sensors are installed on the dressing to collect data on changes in the dressing use environment, conduct continuous real-time monitoring, and generate an environmental monitoring data set; The performance analysis module uses a time series analysis method based on the environmental monitoring data set to screen out the key time periods and environmental conditions that affect the drug release rate and the air permeability of the dressing, summarize the changing rules of the dressing performance, and obtain the dressing performance change analysis results; The drug efficacy encapsulation module selects a wrapping material with anti-oxidation and anti-moisture properties based on the dressing performance change analysis results, performs protective encapsulation on the drug efficacy components, tests the stability of the encapsulation material under different conditions, and generates a drug efficacy component stability adjustment plan; The flow field optimization module adjusts the internal flow field design of the microfluidic chip based on the stability adjustment scheme of the active ingredient, adjusts the flow field layout using experimental testing methods, ensures the distribution and release of the drug as required, and generates flow field layout optimization results; The drug release control module performs a final drug release control test based on the flow field layout optimization result, verifies through experiments whether the distribution and release rate of the drug on the skin meet the treatment requirements, ensures the treatment effect of the dressing, and obtains a drug release control optimization plan.
Citation Information
Patent Citations
Wound dressing and methods of making and using the same
CN101252905A
Systems and methods for wound protection and exudate management
CN102448415A
Transdermal sustained-release drug delivery system and preparation and application method thereof
CN103110668A
Preparation method and application of skin regeneration aerogel type dressing
CN107998444A
Remotely monitored and controlled pulse electrical stimulation flexible electronic chitosan application
CN110665120A
